Adaptive Biotechnologies Corp (ADPT): Shareholders' Equity
$218.79M
As of 2025-12-31
$142.91M
As of 2026-06-30
-22.2%
3-year compound annual growth
-21.7%
5-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $218.79M | +7.9% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $202.71M | -34.3% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $308.40M | -33.6% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $464.17M | -23.2% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $603.99M | -18.7% | 2023-02-14, Balance as of period end |
| 2020-12-31 | $743.27M | +30.2% | 2022-02-15, Balance as of period end |
| 2019-12-31 | $571.04M | n/m | 2021-02-24, Balance as of period end |
| 2018-12-31 | -$258.11M | n/m | 2021-02-24, Balance as of period end |
| 2017-12-31 | -$224.62M | n/a | 2020-02-26, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | $218.79M | +7.9% |
| Vericel Corp (VCEL) | 2025-12-31 | $354.64M | +21.5% |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | $698.58M | -1.7% |
| Vaxart, Inc. (VXRT) | 2025-12-31 | $87.80M | +49.0% |
| Twist Bioscience Corp (TWST) | 2025-09-30 | $472.96M | +0.1% |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $1.22B | +28.9% |
| Immunocore Holdings plc (IMCR) | 2025-12-31 | $381.03M | +5.6% |
| Adaptimmune Therapeutics PLC (ADAPY) | 2024-12-31 | $11.85M | -70.0% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $102.73M | -60.4% |
Compare ADPT, VCEL, IOVA, VXRT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗